NECTAR LIFESCIENCES
Back to Balance Sheet
|
NECTAR LIFESCIENCES Last 5 Year Contingent Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Contingent Liabilities | ₹198 Cr | ₹161 Cr | ₹76 Cr | ₹89 Cr | ₹72 Cr |
What is the latest Contingent Liabilities ratio of NECTAR LIFESCIENCES ?
Year | Contingent Liabilities |
---|---|
Mar2024 | ₹198 Cr |
Mar2023 | ₹161 Cr |
Mar2022 | ₹76 Cr |
Mar2021 | ₹89 Cr |
Mar2020 | ₹72 Cr |
How is Contingent Liabilities of NECTAR LIFESCIENCES Trending?
Years | Contingent Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹198 Cr | 22.75 | |
Mar2023 | ₹161 Cr | 113.41 | |
Mar2022 | ₹76 Cr | -15.46 | |
Mar2021 | ₹89 Cr | 24.86 | |
Mar2020 | ₹72 Cr | - |
Compare Contingent Liabilities of peers of NECTAR LIFESCIENCES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NECTAR LIFESCIENCES | ₹329.0 Cr | -4.1% | -11.7% | -61.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹380,594.0 Cr | -3.3% | -6.9% | -9.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹162,722.0 Cr | 1.7% | -6.8% | 25.4% | Stock Analytics | |
CIPLA | ₹127,508.0 Cr | -0.9% | 0.5% | -0.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,111.0 Cr | -1.9% | -1.3% | 7.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,225.0 Cr | -1.2% | -2% | -9% | Stock Analytics |
NECTAR LIFESCIENCES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NECTAR LIFESCIENCES | -4.1% |
-11.7% |
-61.4% |
SENSEX | -2.2% |
-1.7% |
-1.2% |
You may also like the below Video Courses